Healthcare / Medical Care FacilitiesSaudi
$1.78
-0.03 (-1.66%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $8.8M · quality 61.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$890M
P/E
59.3x
↑EV/EBITDA
40.0x
↑ROE
16.2%
↑Gross Margin
44.1%
↓Debt/Equity
0.01
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+30.6%
FCF CAGR
-7.7%
FCF margin
11.6%
FCF / Net income
0.56x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $76.1M · net income $15.8M · FCF $8.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $76.1M | $76.1M | $53.6M | $51.0M | $34.1M |
| Net Income | $15.8M | $15.8M | $9.9M | $13.7M | $5.1M |
| EBITDA | $21.2M | $21.2M | $13.8M | $16.3M | $6.1M |
| EPS | — | — | 0.02 | 0.03 | 0.01 |
| Gross Margin | 44.1% | 44.1% | 44.1% | 51.8% | 35.9% |
| Operating Margin | 23.9% | 23.9% | 22.6% | 25.1% | 18.0% |
| Net Margin | 20.7% | 20.7% | 18.4% | 26.8% | 15.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.01 | 0.01 | 0.03 | 0.03 | 0.46 |
| Current Ratio | 9.30 | 9.30 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $8.8M | $8.8M | $-1.6M | $19.4M | $11.2M |
| Returns | |||||
| ROE | 16.2% | 16.2% | 11.8% | 18.6% | 102.9% |
| Valuation | |||||
| P/E | 59.33 | 59.33 | 456.50 | 446.67 | 230.00 |
| EV/EBITDA | 40.03 | 40.03 | 326.13 | 407.29 | 182.08 |
| P/B | 9.18 | 9.18 | 54.51 | 90.98 | 230.92 |
| Growth & Yield | |||||
| Revenue Growth | 41.8% | 41.8% | 5.2% | 49.4% | — |
| EPS Growth | — | — | -33.3% | 200.0% | — |
| Dividend Yield | 0.8% | 0.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-48.7%
Start / end P/E
n/dx → n/dx
EPS bridge
0.02 → n/d
Residual
-49.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.